Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room

NCT06178822 is registered in ClinicalTrials.gov with Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) as lead sponsor.

NCT NCT06178822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06178822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
Lead sponsor
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Phase
Observational
Overall status
Recruiting
Start date
October 25, 2022
Completion date
October 1, 2026
Enrollment
3,300 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

infection viral, infection, bacterial, infections, infections, respiratory, sepsis, sepsis, severe, septic shock